Protein C deficiency: From gene defects to disease

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 344-350

  Reitsma, Pieter H ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN C; PROTEIN PRECURSOR;

AMINO ACID SEQUENCE; CHROMOSOME 2Q; CONFERENCE PAPER; FOUNDER EFFECT; GENE MUTATION; HIGH RISK POPULATION; HUMAN; MISSENSE MUTATION; MUTATION RATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN C DEFICIENCY; PROTEIN DOMAIN; RNA PROCESSING; STOP CODON; STRUCTURE ACTIVITY RELATION; VEIN THROMBOSIS;

EID: 0030877833     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657550     Document Type: Conference Paper

References (69)

1. Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6:2561-2567.
2. Dahlback B, Stenflo J. A natural anticoagulant pathway: proteins C, S, C4b-binding protein and thrombomodulin. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Haemostasis and Thrombosis. Edinburgh: Chuchill Livingstone 1994:671-698.
3. Esmon CT, Schwarz HP. An update on clinical and basic aspects of the protein C anticoagulant pathway. Trends Cardiovasc Med 1995; 5:141-148.
4. Poort SR, Michiels JJ, Reitsma PH, Bertina RM. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 1994; 72:819-824.
5. Miyata T, Zheng Y-Z, Kato A, Kato H. A point mutation (Arg271→Cys) of a homozygote for dysfunctional prothrombin, prothrombin Obihiro, which has a region of high sequence variability. Br J Haematol 1995; 90:688-692.
6. Bezeaud A, Miyata T, Helley D, Zeng YZ, Kato H, Aillaud MF, Juhan-Vague I, Guillin MC. Functional consequences of the Ser334→Pro mutation in a human factor X variant (factor XMarseille). European Journal of Biochemistry 1995; 234: 140-147.
7. + factor X deficiency: A frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain. Br J Haematol 1995; 90:910-915.
8. Wenatchee I and II: Compound heterozygosity involving two variant proteins. Biochim Biophys Acta Mol Basis Dis 1995; 1271: 327-334.
9. Ketchikan: A variant molecule in which Gly replaces a G1a residue at position 14 in the light chain. Hum Genet 1995; 95:212-214.
10. Zheng DQ, Shurafa M, James HL. Factor VII G331D: a variant molecule involving replacement of a residue in the substrate-binding region of the catalytic domain. Blood Coagul Fibrinolysis 1996; 7:93-96.
11. Arbini AA, Mannucci M, Bauer KA. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 1996; 87:5085-5094.
12. Bernardi F, Castaman G, Pinotti M, Ferraresi P, Diiasio MG, Lunghi B, Rodeghiero F, Marchetti G. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum Mut 1996; 8:108-115.
13. Giannelli F, Green PM, Sommer SS, et al. Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res 1996; 24:103-118
14. Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C deficiency: A database of mutations, 1995 update. Thromb Haemost 1995; 73:876-889.
15. Borgel D, Duchemin J, Alhencgelas M, Matheron C, Aiach M, Gandrille, S. Molecular basis for protein S hereditary deficiency - genetic defects observed in 118 patients with type I and type IIa deficiencies. J Lab Clin Med 1996; 128:218-227.
16. Foster D, Davie EW. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci USA 1984;81:4766-4770.
17. Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82:4673-4677.
18. Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci U S A 1986; 83:546-550.
19. Patracchini P, Aiello V, Palazzi P, Calzolari E, Bernardi F. Sublocalization of the human protein C gene on chromosome 2q13-q14. Hum Genet 1989; 81:191-192.
20. Foster DC, Rudinski MS, Schach BG, Berkner KL, Kumar AA, Hagen FS, Sprecher CA, Insley MY, Davie EW. Propeptide of human protein C is necessary for gamma-carboxylation. Biochemistry 1987; 26:7003-7011.
21. Wojcik EGC, Simioni P, Berg MVD, Girolami A, Bertina RM. Mutations which introduce free cysteine residues in the Gla-domain of vitamin K-dependent proteins result in the formation of complexes with alpha(1)-microglobulin. Thromb Haemost 1996; 75:70-75.
22. ++. Br J Haematol 1993; 85:521-527.
23. Diuguid DL, Rabiet MJ, Furie BC, Liebman HA, Furie B. Molecular basis of hemophilia B : a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. Proc Natl Acad Sci USA 1986; 83: 5803-5807.
24. Erdjument H, Lane DA, Ireland H, Panico M, Di Marzo V, Blench I, Morris HR. Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin "Northwick Park". J Biol Chem 1987; 262: 13381-13384.
25. Greengard JS, Griffin JH, Fisher CL. Possible structural implications of 20 mutations in the protein C protease domain. Thromb Haemostas 1994; 72:869-873.
26. Wacey AI, Pemberton S, Cooper DN, Kakkar VV, Tuddenham EGD. A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency. Br J Haematol 1993; 84:290-300.
27. Greengard JS, Fisher CL, Villoutreix B, Griffin JH. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimensional molecular modelling of mutations of the protease domain. Proteins 1994; 18:367-380.
28. Hallam PJ, Wacey AI, Mannucci PM, Legnani C, Kuhnau W, Krawczak M, Kakkar VV, Cooper DN. A novel missense mutation (Thr176→Ile) at the putative hinge of the neo N-terminus of activated protein C. Hum Genet 1995; 95:447-450.
29. Millar DS, Wacey AI, Voke J, Kakkar VV, Cooper DN. A novel point mutation (Val 297→Met) in the serine proteinase domain of protein C in a patient with both venous and arterial thromboembolic disease. Blood Coagul Fibrinolysis 1993; 4:631-633.
30. Katsumi A, Senda T, Yamashita Y, Yamazaki T, Hamaguchi M, Kojima T, Kobayashi S, Saito H. Protein C Nagoya, an elongated mutant of protein C, is retained within the endoplasmic reticulum and is associated with GRP78 and GRP94. Blood 1996; 87:4164-4175.
31. Simioni P, Kalafatis M, Millar DS, Henderson SC, Luni S, Cooper DN, Girolami A. Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma. Blood 1996; 88:2101-2108.
32. Spek CA, Greengard JS, Griffin JH, Bertina RM, Reitsma PH. Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem 1995;270:24216-24221.
33. Miao CH, Ho WT, Greenberg DL, Davie EW. Transcriptional regulation of the gene coding for human protein C. J Biol Chem 1996; 271:9587-9594.
34. Berg L, White DA, Alhaq A, Kakkar VV, Cooper DN. Disruption of a binding site for hepatocyte nuclear factor 1 (HNF-1) in the protein C (PROC) gene promoter is associated with hereditary thrombophilia. Hum Mol Genet 1994; 3:2147-2152.
35. Tsay W, Lee YM, Lee SC, Shen MC, Chen PJ. Characterization of human protein C gene promoter - insights from natural human mutants. DNA Cell Biol 1996; 15:907-919.
36. Krawczak M, Cooper DN. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet 1991; 86: 425-441.
37. Soria JM, Morell M, Nicolau I, Estivill X, Sala N. Homozygosity for R87H missense mutation and for a rare intron 7 DNA variant (7054G → A) in the PROC genes of three siblings initially classified as heterozygotes for protein C deficiency. Blood Coagul Fibrinolysis 1996; 7:15-23.
38. Soria JM, Berg LP, Fontcuberta J, Kakkar VV, Estivill X, Cooper DN, Sala N. Ectopic transcript analysis indicates that allelic exclusion is an important cause of type I protein C deficiency in patients with nonsense and frameshift mutations in the PROC gene. Thromb Haemostas 1996; 75:870-876.
39. Berg LP, Soria JM, Formstone CJ, Morell M, Kakkar VV, Estivill X, Sala N, Cooper DN. Aberrant rna splicing of the protein C and protein S genes in healthy individuals. Blood Coagul Fibrinolysis 1996; 7:625-631.
40. Wehinger H, Geiger E, Freudenberg V, Schurmann J, Alexandrakis E, Witt I. Severe hereditary protein C deficiency in a newborn infant with fulminant purpura-successful treatment with phenprocoumon. Klin Padiatr 1985;197:116-120.
41. Rosenberg RD. The absence of the blood clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Thromb Haemost 1995; 74:52-57.
42. Reitsma PH, Poort SR, Allaart CF, Briët E, Bertina RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: Heterogeneity and founder effects. Blood 1991; 78:890-894.
43. Matsuda M, Sugo T, Sakata Y, Murayama H, Mimuro J, Tanabe S, Yoshitake S. A thrombotic state due to an abnormal protein C. N Engl J Med 1988; 319:1265-1268.
44. Grundy CB, Chitolie A, Talbot S, Bevan D, Kakkar V, Cooper DN. Protein C London 1: recurrent mutation at Arg 169 (CGG-TGG) in the protein C gene causing thrombosis. Nucleic Acids Res 1989; 17:10513
45. Grundy CB, Schulman S, Krawczak M, Kobosko J, Kakkar VV, Cooper DN. Protein C deficiency and thromboembolism: Recurrent mutation at Arg 306 in the protein C gene. Hum Genet 1992; 88:586-588.
46. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 78:151-155
47. Krawczak M, Reitsma PH, Cooper DN. The mutational demography of protein C deficiency. Hum Genet 1995;96: 142-146.
48. Reitsma PH, Poort SR, Bernardi F, Gandrille S, Long GL, Sala N, Cooper DN. Protein C deficiency: a database of mutations. Thromb Haemost 1993; 69:77-84.
49. Delvos U, Meusel P, Preissner KT, Muller Berghaus G. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells - a comparative study of two anticoagulant mechanisms. Thromb Haemost 1987;57:87-91.
50. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-213.
51. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68:1370-1373.
52. Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 19; 2:1165-1168.
53. Estelles A, Garcia Plaza I, Dasi A, Aznar J, Duart M, Sanz G, Perez Requejo JL, Espana F, Jimenez C, Abeledo G. Severe inherited "homozygous" protein C deficiency in a newborn infant. Thromb Haemost 1984; 52:53-56.
54. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310:559-562.
55. Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985; 65:15-20.
56. Miletich J, Sherman L, Broze G, Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317:991-996.
57. Hallam PJ, Millar DS, Krawczak M, Kakkar VV, Cooper DN. Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency. J Med Genet 1995; 32:543-545.
58. Koster T, Rosendaal FR, Briët E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden thrombophilia study). Blood 1995; 85:2756-2761.
59. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994;84:1031-1035.
60. Conard J, Horellou MH, Van Dreden P, Samama M, Reitsma PH, Poort SR, Bertina RM. Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin lesions. Lancet 1992; 339:743-744.
61. Grundy CB, Melissari E, Lindo V, Scully MF, Kakkar VV, Cooper DN. Late-onset homozygous protein C deficiency. Lancet 1991; 338:575-576.
62. 286→His mutations. Thromb Haemost 1994; 72:526-533.
63. Soria JM, Brito D, Barcelo J, Fontcuberta J, Botero L, Maldonado J, Estivill X, Sala N. Severe homozygous protein C deficiency: identification of a splice site missense mutation (184, Q→H) in exon 7 of the protein C gene. Thromb Haemost 1994; 72:65-69.
64. Witt I, Beck S, Seydewitz HH, Tasangil C, Schenck W. A novel homozygous missense mutation (Val 325→Ala) in the protein C gene causing neonatal purpura fulminans. Blood Coagul Fibrinolysis 1994; 5:651-653.
65. Millar DS, Allgrove J, Rodeck C, Kakkar VV, Cooper DN. A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal Purpura fulminans: prenatal diagnosis in an at-risk pregnancy. Blood Coagul Fibrinolysis 1994; 5:647-649.
66. Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planché C, Dehan M, Tchernia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325:1565-1568.
67. Gandrille S, Jude B, Alhenc-Gelas M, Millaire A, Aiach M. Compound heterozygosity in a family with protein C deficiency illustrating the complexity of the underlying molecular mechanism. Thromb Haemost 1993; 70:747-752.
68. Sugahara Y, Miura O, Hirosawa S, Aoki N. Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to G1n and Cys-331 to Arg, leading to impaired secretion of mutant protein C. Thromb Haemost 1994; 72:814-818.
69. Spek CA, Koster T, Rosendaal FR, Bertina RM, Reitsma PH. Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb 1995; 15:214-218.